Get the Stockscreener App
91.43
1.91%
1.74
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $91.43, with a volume of 265.70K.
It is up +1.91% in the last 24 hours and down -1.99% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$89.69
Open:
$90.11
24h Volume:
265.70K
Relative Volume:
0.22
Market Cap:
$10.61B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
38.91
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+3.87%
1M Performance:
-1.99%
6M Performance:
-20.53%
1Y Performance:
-23.98%
1-Day Range:
$89.25
$91.88
1-Week Range:
$87.94
$91.88
52-Week Range:
$85.12
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
91.44 | 10.54B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
496.89 | 184.66B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
212.28 | 151.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
638.65 | 52.07B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.74 | 33.86B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.06 | 32.49B | 15.70B | 1.24B | 2.01B | 6.91 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Stock Analysis | Revvity OutlookMixed Signals Amid Industry Growth - AInvest
Revvity to Present at Upcoming Investor Conferences - Business Wire
What makes Revvity Inc. stock price move sharply2025 Bull vs Bear & Reliable Price Action Trade Plans - mustnews.co.kr
Can Revvity Inc. keep up with sector leaders2025 Trading Recap & Long Hold Capital Preservation Plans - newsyoung.net
Published on: 2025-08-16 06:06:34 - sundaytimes.kr
Momentum Traders Eye Revvity Inc. for Quick Bounce2025 Geopolitical Influence & Risk Controlled Swing Alerts - sundaytimes.kr
Can Revvity Inc. be the next market leader2025 Earnings Impact & Safe Entry Momentum Stock Tips - thegnnews.com
Revvity's (NYSE:RVTY) Performance Is Even Better Than Its Earnings Suggest - simplywall.st
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know - TradingView
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Is Revvity's pHSense Launch Shaping Its Innovation Strategy and Consumables Revenue Mix (RVTY)? - simplywall.st
Stock Market Rally: Revvity, Avantor, Azenta, Bio-Techne, Amneal Shares Surge Amid Fed Interest Rate Cut Hopes - AInvest
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - TradingView
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity’s pHSense Enables High Throughput Internalization - Precedence Research
Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN
Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics - Lelezard
Revvity Unveils PHSense Reagents To Advance Internalization Studies In Drug Discovery - 富途牛牛
Revvity launches innovative reagent technology to accelerate therapeutics development - BioSpectrum Asia
Revvity Launches Innovative Reagent Technology to Accelerate Dev - GuruFocus
Revolutionary Lab Technology by Revvity Promises to Cut Drug Development Time in Half - Stock Titan
Revvity 2025 Q2 Earnings Sustained Profitability Amid Slight Earnings Decline - AInvest
3 Healthcare Stocks to Avoid: GE HealthCare, Universal Health Services, and Revvity - AInvest
Earnings Preview: What to Expect From Revvity's Report - MSN
What's Going On With Revvity Stock Today? - 富途牛牛
Screener Results Flag Revvity Inc. as OversoldTriple Digit Return Stock Predictions Released - metal.it
Revvity Inc.’s Price Action Aligns with Quant SignalsBreakout Confirmation With Entry Tracker Enabled - metal.it
Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - 富途牛牛
Is it the right time to buy Revvity Inc. stockTurn volatility into profit opportunities - Jammu Links News
What are Revvity Inc. company’s key revenue driversOutstanding capital appreciation - Jammu Links News
What are the technical indicators suggesting about Revvity Inc.Consistent high-performance stocks - Jammu Links News
How does Revvity Inc. generate profit in a changing economyConsistently superior profits - Jammu Links News
What is the dividend policy of Revvity Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News
Revvity, Inc. Stock (RVTY) Opinions on Quarterly Earnings Report - Quiver Quantitative
What is the risk reward ratio of investing in Revvity Inc. stockUnlock steady growth with low-risk stocks - Jammu Links News
Is Revvity Inc. a good long term investmentExceptional trading results - Jammu Links News
Does Revvity Inc. stock perform well during market downturnsInvest confidently with real-time updates - Jammu Links News
How many analysts rate Revvity Inc. as a “Buy”Achieve consistent double-digit growth - Jammu Links News
Why is Revvity Inc. stock attracting strong analyst attentionFree Capital Efficiency Planning - Jammu Links News
When is Revvity Inc. stock expected to show significant growthGain the edge with real-time market data - Jammu Links News
What institutional investors are buying Revvity Inc. stockHigh-yield trading alerts - Jammu Links News
How strong is Revvity Inc. company’s balance sheetFree Technical Analysis Support - Jammu Links News
Is Revvity Inc. a growth stock or a value stockBest Dividend Forecasts To Watch Now - Jammu Links News
Revvity stock hits 52-week low at 87.63 USD - Investing.com Australia
Revvity stock hits 52-week low at 87.63 USD By Investing.com - Investing.com Canada
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.94%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):